Treatment of Thyroid Diseases and Long‑Term Health Effects

A randomized controlled trial conducted by Ruijin Hospital, Shanghai Jiao Tong University School of Medicine showed that adding methotrexate 10 mg/week to standard thiamazole treatment significantly improved the remission rate off medication in patients with Graves’ disease (GD) at 15–18 months (55.6% vs. 38.9%) and accelerated the reduction of TSH receptor antibody (TRAb) levels, with […]

Medications for Type 2 Diabetes with Obesity

For patients with type 2 diabetes mellitus (T2DM) and obesity, pharmacotherapy should achieve both glycemic control and weight reduction. Based on extensive research and multiple medical guidelines, the following is a recommended medication strategy for such patients.I. Cornerstone Drug: Metformin (First-Line)As a first-line agent, metformin acts through unique mechanisms: It achieves dual benefits: glucose lowering […]

Tailoring the Choice of Weight-Loss Medications in Clinical Practice

Professor Xu Danyan, from the Department of Metabolic Cardiology at the Second Xiangya Hospital of Central South University, believes that if a healthy lifestyle is the foundation for fighting obesity, then weight-loss medications are the lever. With advances in medicine, the options for weight-loss medications have become more diverse, and they are currently categorized into […]

Intervention and Treatment of Postmenopausal Sarcopenic Obesity

Exercise Intervention: Multiple guidelines recommend resistance training as the core strategy for treating SO. Studies in postmenopausal women confirm that regular resistance training can significantly improve muscle strength and body composition, including increasing lean body mass and reducing fat percentage, in a safe and feasible manner.Nutritional Intervention: According to the ESPEN (European Society for Clinical […]

Clinical Consensus on Glycemic Management: Emphasizing Both Efficacy and Safety, with Consideration for Weight Control and Long-Term Benefits

Professor Chen Haibing from Shanghai Tenth People’s Hospital (Affiliated Tenth People’s Hospital of Tongji University) points out that diabetes is a highly heterogeneous disease driven by multiple factors in its onset and progression. Meanwhile, patients with diabetes often present with various comorbidities and complications, requiring comprehensive consideration in management. Pharmacotherapy should be administered when necessary […]

The Core of Precision Obesity Treatment is Patient-Centered Individualized Diagnosis and Therapy

Professor Hong Tianpei of Peking University Third Hospital holds that, with the continuous emergence of novel weight-loss medications — such as more potent GLP‑1 agents, GIP/GLP‑1 dual-target and triple-target agonists — clinical decision-making has become increasingly complex. Individualized regimens should be formulated by integrating patient phenotypes, drug mechanisms, weight-loss magnitude, metabolic improvement effects, and safety […]

Precision: The Inevitable Trend for Future Obesity Management

Professor Hong Tianpei of Peking University Third Hospital delivered a keynote report entitled Precision Therapy for Obesity: Opportunities and Challenges at the 2025 Peking University Diabetes Forum & Coastal Changqiao Metabolic Diseases Research Symposium. He shared insights on why precision represents the inevitable trend in future obesity management.Professor Hong Tianpei pointed out that obesity has […]

Tiptozumab N01 Injection: TED Treatment Enters the Era of Precision Targeting

Thyroid Eye Disease (TED) is an organ-specific autoimmune disease closely associated with thyroid disorders. Patients face not only the risks of exophthalmos, diplopia, eye pain, vision loss and even blindness, but also psychological problems such as anxiety and social barriers caused by facial changes. Traditional treatments have limited efficacy or side effect risks, creating an […]